The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics

American Journal of Clinical Pathology

Volumn 135, Issue 4, 2011, Pages 611-618

  Sterlacci, William ^a   Tzankov, Alexandar ^b   Veits, Lothar ^c   Oberaigner, Wilhelm ^d   Schmid, Thomas ^e   Hilbe, Wolfgang ^f   Fiegl, Michael ^f  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Institute for Pathology   (Austria)

^d Institute for Clinical Epidemiology   (Austria)

^e Department of Visceral Transplantation and Thoracic Surgery   (Austria)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Non small cell lung cancer; Prognostic factor; Sex

Indexed keywords

KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER GRADING; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SURVIVAL TIME; TISSUE MICROARRAY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, MUCOEPIDERMOID; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CARCINOSARCOMA; FEMALE; HUMANS; KI-67 ANTIGEN; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SEX FACTORS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79954583372     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPQF24NYWNMVMG     Document Type: Article

References (36)

1. Fu JB, Kau TY, Severson RK, et al. Lung cancer in women: Analysis of the national Surveillance, Epidemiology, and End Results database. Chest. 2005;127:768-777. (Pubitemid 40775504)
2. Moore R, Doherty D, Chamberlain R, et al. Sex differences in survival in non-small cell lung cancer patients 1974-1998. Acta Oncol. 2004;43:57-64. (Pubitemid 38283174)
3. Kirsch MM, Tashian J, Sloan H. Carcinoma of the lung in women. Ann Thorac Surg. 1982;34:34-39. (Pubitemid 12080752)
4. Shafer D, Albain K. Lung cancer outcomes in women. Semin Oncol. 2009;36:532-541.
5. Hsu LH, Chu NM, Liu CC, et al. Sex-associated differences in non-small cell lung cancer in the new era: Is gender an independent prognostic factor? Lung Cancer. 2009;66:262-267.
6. Chang JW, Asamura H, Kawachi R, et al. Gender difference in survival of resected non-small cell lung cancer: Histology-related phenomenon? J Thorac Cardiovasc Surg. 2009;137:807-812.
7. Båtevik R, Grong K, Segadal L, et al. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: A study of absolute and relative survival over 15 years. Lung Cancer. 2005;47:173-181. (Pubitemid 40082160)
8. Andrews JL Jr, Bloom S, Balogh K, et al. Lung cancer in women. Cancer. 1985;55:2894-2898.
9. Travis WD, Lubin J, Ries L, et al. United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females. Cancer. 1996;77:2464-2470. (Pubitemid 26169142)
10. Visbal AL, Williams BA, Nichols FC III, et al. Gender differences in non-small-cell lung cancer survival: An analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg. 2004;78:209-215. (Pubitemid 38842439)
11. Jung SY, Han W, Lee JW, et al. Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer. Ann Surg Oncol. 2009;16:1112-1121.
12. Wolfsberger S, Fischer I, Höftberger R, et al. Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma. Am J Surg Pathol. 2004;28:914-920. (Pubitemid 38856848)
13. Travis W, Brambilla E, Müller-Hermelink H, et al, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004. WHO Classification of Tumours; vol 10.
14. Sterlacci W, Fiegl M, Hilbe W, et al. Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: A retrospective study on 405 surgically resected cases. Virchows Arch. 2009;455:125-132.
15. Fiegl M, Hilbe W, Auberger J, et al. Twelve-year retrospective analysis of lung cancer: The TYROL Study: Daily routine in 1,424 patients (1995-2006) [abstract]. J Clin Oncol. 2008;26(suppl):abstract 19063.
16. Hilbe W, Aigner K, Dittrich C, et al. Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms [in German]. Wien Klin Wochenschr. 2007;119:259-266. (Pubitemid 46895797)
17. Sterlacci W, Fiegl M, Hilbe W, et al. Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients. J Thorac Oncol. 2010;5:1325-1336.
18. Tzankov A, Zlobec I, Went P, et al. Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores. Leuk Lymphoma. 2010;51:199-212.
19. Chatkin JM, Abreu CM, Fritscher CC, et al. Is there a gender difference in non-small cell lung cancer survival? Gend Med. 2004;1:41-47. (Pubitemid 40185845)
20. Cerfolio RJ, Bryant AS, Scott E, et al. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest. 2006;130:1796-1802. (Pubitemid 46033436)
21. Jänne PA, Gurubhagavatula S, Yeap BY, et al. Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study. Lung Cancer. 2004;44:221-230. (Pubitemid 38482055)
22. Keller SM, Vangel MG, Adak S, et al. The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer. Lung Cancer. 2002;37:303-309. (Pubitemid 35286730)
23. Raz DJ, He B, Rosell R, et al. Bronchioloalveolar carcinoma: A review. Clin Lung Cancer. 2006;7:313-322. (Pubitemid 43950978)
24. Agudo A, Ahrens W, Benhamou E, et al. Lung cancer and cigarette smoking in women: A multicenter case-control study in Europe. Int J Cancer. 2000;88:820-827.
25. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: Age, smoking, histology, performance status, stage, initial treatment and survival: Population-based study of 20,561 cases. Ann Oncol. 2002;13:1087-1093.
26. Wang TJ, Zhou BS, Shi JP. Lung cancer in nonsmoking Chinese women: A case-control study. Lung Cancer. 1996;14:93-98.
27. Sobue T, Yamamoto S, Hara M, et al. Cigarette smoking and subsequent risk of lung cancer by histologic type in middleaged Japanese men and women: The JPHC study. Int J Cancer. 2002;99:245-251. (Pubitemid 34309482)
28. Tzankov A, Went P, Zimpfer A, et al. Tissue microarray technology: Principles, pitfalls and perspectives: Lessons learned from hematological malignancies. Exp Gerontol. 2005;40:737-744. (Pubitemid 41265824)
29. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000;80:1943-1949. (Pubitemid 32012762)
30. Hartmann EM, Ott G, Rosenwald A. Molecular outcome prediction in mantle cell lymphoma. Future Oncol. 2009;5:63-73.
31. Hanagiri T, Sugio K, Uramoto H, et al. Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer. Surg Today. 2007;37:546-551. (Pubitemid 46998945)
32. Sculier JP, Chansky K, Crowley JJ, et al. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol. 2008;3:457-466. (Pubitemid 351630271)
33. Sekine I, Sumi M, Ito Y, et al. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy. Jpn J Clin Oncol. 2009;39:707-712.
34. Cerny D, Cerny T, Ess S, et al. Lung cancer in the Canton of St. Gallen, Eastern Switzerland: Sex-associated differences in smoking habits, disease presentation and survival. Onkologie. 2009;32:569-573.
35. Albain KS, Crowley JJ, LeBlanc M, et al. Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience. J Clin Oncol. 1991;9:1618-1626.
36. Wakelee HA, Bernardo P, Johnson DH, et al. Changes in the natural history of nonsmall cell lung cancer (NSCLC): Comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990. Cancer. 2006;106:2208-2217. (Pubitemid 43673243)